Renalytix Surges 24% as Long-Term Data Strengthens the Investment Story
Renalytix shares surged 24% after new two-year clinical data reinforced the effectiveness of its AI-powered KidneyIntelX test. More importantly for investors, the results strengthen the company’s commercial case, shifting the focus from proving the science to proving the business.
Asia Enters the AI Infrastructure Buildout: South Korea’s $1B Bet and What It Signals for Markets
AI is entering an infrastructure-driven phase, and South Korea’s $1 billion bet on data centres and computing systems reinforces the idea that the next wave of growth will be powered by chips, energy, and large-scale hardware buildout.
English 
German